GlaxoSmithKline and Sanofi Pasteur could supply vaccine by early next year if it is successful
The government has signed a deal with the pharmaceutical firms GlaxoSmithKline (GSK) and Sanofi Pasteur for 60m doses of a potential Covid-19 vaccine.
If the vaccine proves successful, the UK could begin to vaccinate priority groups, such as frontline health and social care workers and those at increased risk from coronavirus, as early as the first half of next year, the Department for Business, Energy and Industrial Strategy said.
Related: Coronavirus vaccine tracker: how close are we to a vaccine?
